Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 150, 112036
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Anhui Science and Technology Department
This publication has 47 references indexed in Scilit:
- Timosaponin AIII inhibits melanoma cell migration by suppressing COX‐2 and in vivo tumor metastasisCancer Science, 2016
- The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2Oncogene, 2013
- Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcomaCancer Letters, 2013
- Roles of microRNA on cancer cell metabolismJournal of Translational Medicine, 2012
- MiR-1246: A new link of the p53 family with cancer and Down syndromeCell Cycle, 2012
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- Protocatechuic acid inhibits cancer cell metastasis involving the down‐regulation of Ras/Akt/NF‐κB pathway and MMP‐2 production by targeting RhoB activationBritish Journal of Pharmacology, 2010
- Timosaponin A-III Induces Autophagy Preceding Mitochondria-Mediated Apoptosis in HeLa Cancer CellsCancer Research, 2008
- Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein KinasesScience, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002